Molecular Carcinogenesis publishes articles describing discoveries in basic and clinical science of the mechanisms involved in chemical-, environmental-, physical (e.g., radiation, trauma)-, infection and inflammation-associated cancer development, basic mechanisms of cancer prevention and therapy, the function of oncogenes and tumors suppressors, and the role of biomarkers for cancer risk prediction, molecular diagnosis and prognosis.


Areas of interest include but are not limited to:
Molecular and cellular mechanisms associated with normal homeostasis altered in neoplasia
Molecular aspects of oncogenes, tumor suppressors, and their gene products in animal models and human cancer
Epigenetic mechanisms related to cancer initiation, progression and therapy
Microenvironment and systemic regulations in cancer initiation and progression
Mechanisms of chemo- and dietary cancer prevention
Molecular cancer epidemiology
Biomarker discoveries for cancer risks, molecular pathology, prognosis and therapeutic response/resistance
Mechanisms of developmental and approved cancer therapeutics and clinical trials (targeted-, immuno-, chemo-, radio-therapy) with clear molecular/cellular targets
Biostatistics, bioinformatics and computational approaches for the aforementioned areas


Areas outside the scope of the journal include:
Studies with no relevance to cancer
Reporting genetic variants without functional validation
Data mining from published data or publically available database without experimental validations
Randomized clinical trials without a molecular target
Research in a cell-free system or a single cell line unless scientifically justified